诺华公司Novartis AG (NVS) 2007年年度报告「NYSE」.pdf

1、ANNUAL REPORT 20071We want to discover,develop and successfully marketinnovative products to prevent and cure diseases,toease suffering and to enhance the quality of life.We also want to provide a shareholder return that reflectsoutstanding performance and to adequately reward those who invest ideas

2、 and work in our company.OUR MISSIONBUSINESS REVIEWOverview2Letter from Daniel Vasella5Pharmaceuticals14Vaccines and Diagnostics34Sandoz42Consumer Health52CORPORATE CITIZENSHIPIntroduction60Commitment to Patients71Commitment to People81and CommunitiesCommitment to the Environment89Commitment to Ethi

3、cal96Business ConductIndependent Assurance Report101CORPORATE GOVERNANCECommitment to103Corporate GovernanceBoard of Directors118Executive Committee124REMUNERATION REPORTRemuneration Report128NOVARTIS GROUP FINANCIAL REPORT 2007Contents141Operating&Financial Review144Equity Strategy175Novartis Group

4、 Consolidated178Financial StatementsNovartis AG Financial Statements244Photo References 252Key Dates 2008256Contact Information256CONTENTSF O R I N F O R M AT I O N O N P H O T O G R A P H S I N T H I S A N N U A L R E P O R T,P L E A S E R E F E R T O PA G E S 2 5 2 T O 2 5 42N O VA R T I S G R O U

5、 P A N N UA L R E P O R TKEY FIGURES(In USD millions,unless indicated otherwise)20072006Total Group net sales39 80037 020Continuing operations1-Net sales38 072 34 393-Operating income excluding environmental and restructuring charges27 8157 642-Return on net sales2(%)20.522.2-Operating income6 7817

6、642-Net income6 5406 825Net income Discontinued operations5 428377Net income Total Group11 9687 202Basic earnings per share3-Continuing operations12.812.90-Total Group5.153.06R&D investments16 4305 321-As%of net sales116.915.5Number of associates(FTE1,4)98 20094 241SHARE INFORMATION20072006Return on